HIMS (HIMS)

$6.3B
Market Cap
53.7
P/E Ratio
2.31
Beta
Dividend Yield
Piotroski 4/9Beneish M -0.34 Flag (> −2.22)

Quantitative Summary

Deterministic

Financial health is average: Piotroski 4/9. Beneish M-Score of -0.34 exceeds the -2.22 academic threshold — earnings quality may warrant further review.

Generated deterministically from quant metrics and financial statements. Not a recommendation.

Algorithmic Teardown

AI-Generated

The capital efficiency profile reveals a significant divergence between revenue expansion and value creation, characterized by a modest ROIC of 4.8% that fails to outpace the cost of equity implied in current valuations. While the DuPont decomposition highlights exceptional operational leverage with gross margins at 73.8%, this is counterbalanced by thin net margins of only 5.5%, suggesting high fixed costs or aggressive pricing dynamics limit bottom-line translation. Fundamental stability metrics present a mixed picture; the Piotroski F-Score of 4/9 indicates moderate financial health without strong momentum, while a Beneish M-Score of -0.34 suggests earnings are not currently under significant manipulation pressure despite the rapid top-line growth trajectory.

Valuation multiples reflect extreme market optimism relative to historical norms and sector peers, with a current P/E ratio of 53.7x implying that investors have priced in sustained high-growth execution far beyond what the modest net margin structure supports. A DCF analysis indicates a fair value of $6, which stands in stark contrast to the multiple expansion required for the stock's price to align with intrinsic worth given its current earnings yield. This discrepancy suggests the market is pricing in an acceleration of profitability or leverage that has not yet materialized in the income statement, creating a wide gap between implied future performance and realized fundamentals.

The risk-reward profile appears skewed toward downside volatility if growth decelerates, as the high valuation leaves little margin for error regarding execution risks highlighted by the middling Piotroski score. While the low Beneish M-Score offers some comfort regarding accounting integrity, the combination of sub-par ROIC and a P/E multiple more than double typical thresholds indicates that any stumble in revenue growth or margin compression could trigger a sharp re-rating toward intrinsic value levels.

Generated by LLM from quantitative data inputs. May contain inaccuracies. Not investment advice.

DCF Sandbox

Interactive

Sensitivity Matrix

TG ↓ / WACC →8%10%12%
2%$8$5$3
3%$10$6$4
4%$12$7$4

Center = base case. Green = >10% upside, Red = >10% downside vs .

Pre-computed DCF: WACC=10.0%, terminal growth 3%. Fair value $6 (+0.0%). Not investment advice.

Price Chart with Moving Averages

Loading chart...
SMA 50 SMA 200

Quant Health Deep Dive

4/9
Piotroski F-Score
Average — mixed operational signals
-0.34
Beneish M-Score
Above threshold — earnings quality may warrant further review per Beneish model. Threshold: <-2.22 = below threshold.

Profitability & Value Creation

73.8%
Gross Margin
5.5%
Net Margin
4.8%
ROIC
+59.0%
Revenue Growth (YoY)
+1.8%
Earnings Growth (YoY)
57.4M
Free Cash Flow

Balance Sheet Health

2.98x
Debt / Equity
1.90x
Current Ratio
4.6x
Net Debt / EBITDA
160.1M
EBITDA

Earnings Surprise History

Q4
✓ Beat
Est: $0.12
Act: $0.20
+65.0%
Q3
✓ Beat
Est: $0.16
Act: $0.17
+3.2%
Q2
✗ Miss
Est: $0.10
Act: $0.06
-41.0%
Q1
✓ Beat
Est: $0.04
Act: $0.08
+92.5%

EPS estimates vs actuals for the most recent reported quarters. Source: yfinance.

Underwater (Drawdown from Peak)

How far below the all-time high the price has been over time. Deeper = more pain for holders.

Loading drawdown chart...

Rolling 60-Day Beta vs S&P 500 (VOO)

How the stock's sensitivity to market moves changes over time. β > 1 = more volatile than the market.

Loading beta chart...
Rolling Beta Market (β = 1.0)

Fundamentals

19.9
Forward P/E
2.34
PEG Ratio
11.52
Price/Book
40M
Avg Volume
$70.43
52W High
$13.74
52W Low
52W Range Position

Passive Flow Attribution

ETF Draft Effect
$354M
Tracked Passive Exposure
8
ETFs Holding HIMS
0.09%
Avg Weight in ETFs
$382B
Total ETF AUM

When investors buy or sell ETFs like XHS or MDYG, the fund manager is mechanically forced to buy or sell HIMS shares regardless of HIMS's individual fundamentals. We estimate $354M of passive capital is structurally linked to HIMS through 8 tracked ETFs. Passive flows have a limited but growing influence on HIMS's daily trading dynamics.

Passive exposure = Σ (ETF AUM × stock weight in ETF) across 8 tracked ETFs. Actual passive ownership is larger (includes mutual funds). Not investment advice.

ETF Contagion Visualizer

Simulate a price drop in HIMS to visualize passive redemption contagion across ETFs and collateral stocks.

HIMS Shock
-0%
Est. Passive Redemption
$0
Systemic Risk
STABLE
HIMSEpicenterVBETFVXFETFVBKETFFLEXMed RiskHUMLow RiskBELow RiskCLOVUnknownCNCMed Risk
HIMS Price Drop (%)0

If HIMS (HIMS) experiences a significant drawdown, ETF redemptions can create collateral selling pressure on co-held stocks. Our model identifies FLEX LTD (FLEX) as the most exposed collateral stock, sharing 2 ETFs with HIMS. This is the "Passive Contagion" effect described in the Inelastic Market Hypothesis.

Contagion model based on shared ETF exposure and constituent weights across 10 tracked ETFs. Estimated selling pressure is a simplified model — actual impact depends on market liquidity, ETF redemption mechanics, and market-maker activity.

HIMS Ownership Dynamics

Ticker
HIMS

Float lock-up computed from 10 ETFs tracked by SecuritiesDB. Actual passive ownership is higher (includes mutual funds, pension funds, etc.).

HIMS Capital Efficiency

How efficiently does HIMS convert operating profits into free cash? The FCF Conversion ratio measures the gap between accounting earnings and real cash generation.

Free Cash Flow
$57M
EBITDA
$160M
FCF Conversion
36%
Reinvestment Rate
64%
36% of EBITDA → Free Cash
0% (cash burn)25% (low)50% (efficient)100% (pure cash)

HIMS converts 36% of its EBITDA into free cash flow, a moderate conversion rate — significant EBITDA is consumed by capital expenditures, working capital changes, or interest payments. The 64% reinvestment rate signals aggressive capacity expansion.

Capital efficiency = Free Cash Flow ÷ EBITDA. Reinvestment = (EBITDA − FCF) ÷ EBITDA. Metrics from latest annual filings. Not investment advice.

Fails-to-Deliver (FTD) History

SEC-reported settlement failures. Elevated FTDs can indicate high short-selling pressure, operational settlement issues, or naked shorting activity.

DateFailed SharesClose PriceNotional Value
2026-05-14130,887$24.14$3.2M
2026-05-1354,825$25.03$1.4M
2026-05-1265$29.14$1,894.1
2026-05-1183,287$28.27$2.4M
2026-05-0819,753$25.65$506,664.45
2026-05-07325,394$26.88$8.7M
2026-05-0512$27.27$327.24
2026-05-01117,171$27.17$3.2M
2026-04-30479,427$26.33$12.6M
2026-04-29283,580$27.91$7.9M
2026-04-28222,277$29.39$6.5M
2026-04-27232,328$30.56$7.1M
2026-04-248,942$28.15$251,717.3
2026-04-23102,119$29.01$3.0M
2026-04-223,364$29.76$100,112.64
2026-04-21353,077$31.01$10.9M
2026-04-20291,876$28.82$8.4M
2026-04-171,943,284$26.99$52.4M
2026-04-15119,079$21.36$2.5M
2026-04-14304,542$21.15$6.4M
2026-04-134,759$19.43$92,467.37
2026-04-104,346$19.75$85,833.5
2026-04-096,533$19.39$126,674.87
2026-04-08420$19.50$8,190
2026-04-07283,943$20.33$5.8M
2026-04-0678,389$19.14$1.5M
2026-04-0275,842$19.84$1.5M
2026-04-01392,872$20.76$8.2M
2026-03-31367,006$18.78$6.9M
2026-03-30218,841$19.38$4.2M

Source: SEC Regulation SHO FTD data. Data is reported with a ~30 day delay. High FTD quantities relative to average daily volume may indicate settlement stress.

Compare HIMS to Peers

Quant metrics computed deterministically from financial statements and price data. Updated: N/A.

SecuritiesDB provides programmatic data aggregation for informational purposes only. None of the metrics, summaries, or algorithmic flags constitute a recommendation to buy or sell any security.